Prothena Shareholder Alert – PRTA Stock Drops Almost 70%
Prothena Discontinues Development of NEOD001 for AL Amyloidosis; PRTA Stock Drops $25.34, or 68.78%, to Close at $11.50 on April 23, 2018 Kehoe Law Firm, P.C. is conducting a securities investigation on behalf of investors of Prothena Corporation plc (NASDAQ:... Read More →